October 4, 2019
Kissei President Yoshio Furihata Kissei Pharmaceutical intends to promote its biosimilar version of Kyowa Kirin’s renal anemia drug Nesp (darbepoetin alfa), which was approved on September 20, by taking advantage of its position in the renal anemia area established through...read more